SOFIA (Bulgaria), July 30 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its non-consolidated net profit went down by an annual 1.7% to 24.6 million levs ($16.9 million/12.6 million euro) in the first half of 2014.